Ivacaftor for Chronic Obstructive Pulmonary Disease – Results from a Phase II, Randomized Controlled Trial

Researchers conducted a Phase II, randomized, double blind placebo control trial to determine safety and tolerability, and explore the potential mechanism of ivacaftor for the treatment of COPD.